2023-04-13 17:26:40 ET
- Anika Therapeutics ( NASDAQ: ANIK ) on Thursday said it had entered into an agreement with investment advisory firm Caligan Partners.
- Under the cooperation agreement, Caligan's Gary Fischetti will join ANIK's board, which will be expanded to eight directors.
- "Fischetti will join two existing board members on a newly formed Capital Allocation Committee of the Board, which will make recommendations to the Board and support management’s review of the Company’s capital allocation," ANIK said in a statement .
- ANIK also said its board had authorized a $20M share buyback which would replace the company's share repurchase program that was announced in May 2019.
- Anika Therapeutics ( ANIK ) stock earlier closed largely unchanged at $27.22.
For further details see:
Anika Therapeutics inks cooperation deal with Caligan Partners, adds director to board